Journal
SCIENCE ADVANCES
Volume 6, Issue 1, Pages -Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.aaw6443
Keywords
-
Categories
Funding
- U.S. NIH [NIH AI105887, AI131703, AI140761, AI150241, AI150514, CA221290]
Ask authors/readers for more resources
Regulatory T cell (T-reg) activation and expansion occur during neonatal life and inflammation to establish immunosuppression, yet the mechanisms governing these events are incompletely understood. We report that the transcriptional regulator c-Myc (Myc) controls immune homeostasis through regulation of T-reg accumulation and functional activation. Myc activity is enriched in T-regs generated during neonatal life and responding to inflammation. Myc-deficient T-regs show defects in accumulation and ability to transition to an activated state. Consequently, loss of Myc in T-regs results in an early-onset autoimmune disorder accompanied by uncontrolled effector CD4(+) and CD8(+) T cell responses. Mechanistically, Myc regulates mitochondrial oxidative metabolism but is dispensable for fatty acid oxidation (FAO). Indeed, T-re(g)-specific deletion of Cox10, which promotes oxidative phosphorylation, but not Cpt1a, the rate-limiting enzyme for FAO, results in impaired T-reg function and maturation. Thus, Myc coordinates T-reg accumulation, transitional activation, and metabolic programming to orchestrate immune homeostasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available